• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺神经内分泌肿瘤:266 例临床病理特征、免疫表型和预后研究。

Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.

机构信息

Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, 20 Xi-Si Road, Nantong, 226001, Jiangsu, China.

Nantong University, Nantong, Jiangsu, China.

出版信息

J Cancer Res Clin Oncol. 2023 Mar;149(3):1063-1077. doi: 10.1007/s00432-022-03970-x. Epub 2022 Mar 6.

DOI:10.1007/s00432-022-03970-x
PMID:35249158
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9984511/
Abstract

OBJECTIVE

Pulmonary neuroendocrine tumors (PNETs) consist of small-cell lung cancer (SCLC), large-cell neuroendocrine carcinoma (LCNEC), typical carcinoid (TC), and atypical carcinoid (AC). We aimed to analyze the immunophenotypic, metastatic, and prognostic risk factors for PNETs.

MATERIALS AND METHODS

A total of 266 patients with PNETs were enrolled, including 219 patients with SCLC, 18 patients with LCNEC, 11 patients with TC, and 18 patients with AC. Clinicopathological characteristics and immunophenotypes were compared among the subtypes of PNETs. Risk factors for metastasis, progression-free survival (PFS), and overall survival (OS) were analyzed.

RESULTS

Thyroid transcription factor-1 (TTF-1) and the Ki-67 index were significantly different among subtypes of PNETs (all P < 0.05). Smoking (OR, 2.633; P = 0.031), high pretreatment carcinoembryonic antigen (CEA > 5 ng/ml: OR, 3.084; P = 0.014), and poorly differentiated pathotypes (P = 0.001) were independent risk factors for lymph-node metastasis. Smoking (OR, 2.071; P = 0.027) and high pretreatment CEA (OR, 2.260; P = 0.007) were independent risk factors for distant metastasis. Results of the multivariate Cox regression model showed pretreatment CEA (HR, 1.674; P = 0.008) and lymphocyte-monocyte ratio (LMR) (HR = 0.478, P = 0.007) were significantly associated with PFS; BMI (P = 0.031), lymph-node metastasis (HR = 4.534, P = 0.001), poorly differentiated pathotypes (P = 0.015), platelet-lymphocyte ratio (PLR) (HR = 2.305, P = 0.004), and LMR (HR = 0.524, P = 0.045) were significantly associated with OS.

CONCLUSIONS

PNETs are a group of highly heterogeneous tumors with different clinical manifestations, pathological features, and prognoses. Knowing clinicopathological characteristics and immunophenotypes of PNETs is significant for diagnosis. Pretreatment PLR, LMR, and CEA have certain value in the prognosis of PNETs.

摘要

目的

肺神经内分泌肿瘤(PNETs)包括小细胞肺癌(SCLC)、大细胞神经内分泌癌(LCNEC)、典型类癌(TC)和非典型类癌(AC)。本研究旨在分析 PNETs 的免疫表型、转移和预后危险因素。

材料与方法

共纳入 266 例 PNETs 患者,包括 219 例 SCLC、18 例 LCNEC、11 例 TC 和 18 例 AC。比较不同 PNETs 亚型的临床病理特征和免疫表型。分析转移、无进展生存期(PFS)和总生存期(OS)的危险因素。

结果

甲状腺转录因子-1(TTF-1)和 Ki-67 指数在不同 PNETs 亚型之间存在显著差异(均 P<0.05)。吸烟(OR,2.633;P=0.031)、高术前癌胚抗原(CEA>5ng/ml:OR,3.084;P=0.014)和低分化组织学类型(P=0.001)是淋巴结转移的独立危险因素。吸烟(OR,2.071;P=0.027)和高术前 CEA(OR,2.260;P=0.007)是远处转移的独立危险因素。多因素 Cox 回归模型结果显示,术前 CEA(HR,1.674;P=0.008)和淋巴细胞-单核细胞比值(LMR)(HR=0.478,P=0.007)与 PFS 显著相关;BMI(P=0.031)、淋巴结转移(HR=4.534,P=0.001)、低分化组织学类型(P=0.015)、血小板-淋巴细胞比值(PLR)(HR=2.305,P=0.004)和 LMR(HR=0.524,P=0.045)与 OS 显著相关。

结论

PNETs 是一组具有不同临床表现、病理特征和预后的高度异质性肿瘤。了解 PNETs 的临床病理特征和免疫表型对诊断具有重要意义。术前 PLR、LMR 和 CEA 对 PNETs 的预后具有一定的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11797249/82743c8ce80f/432_2022_3970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11797249/b58c4242c2d7/432_2022_3970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11797249/22aface3dae4/432_2022_3970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11797249/82743c8ce80f/432_2022_3970_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11797249/b58c4242c2d7/432_2022_3970_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11797249/22aface3dae4/432_2022_3970_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b207/11797249/82743c8ce80f/432_2022_3970_Fig3_HTML.jpg

相似文献

1
Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.肺神经内分泌肿瘤:266 例临床病理特征、免疫表型和预后研究。
J Cancer Res Clin Oncol. 2023 Mar;149(3):1063-1077. doi: 10.1007/s00432-022-03970-x. Epub 2022 Mar 6.
2
Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).中国肺神经内分泌肿瘤基因组全景特征分析揭示预后和治疗标志物(CSWOG-1901)。
Oncologist. 2022 Mar 4;27(2):e116-e125. doi: 10.1093/oncolo/oyab044.
3
Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.肺神经内分泌肿瘤 90 例临床病理特征、免疫表型、术前活检及冷冻切片诊断研究
J Surg Oncol. 2014 Mar;109(3):280-6. doi: 10.1002/jso.23497. Epub 2013 Dec 3.
4
Value of markers of systemic inflammation for the prediction of postoperative progression in patients with pancreatic neuroendocrine tumors.系统性炎症标志物对预测胰腺神经内分泌肿瘤患者术后进展的价值。
Front Endocrinol (Lausanne). 2024 Feb 1;15:1293842. doi: 10.3389/fendo.2024.1293842. eCollection 2024.
5
Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.200例肺神经内分泌肿瘤的生存分析及非典型类癌标准的明确及其与典型类癌的鉴别
Am J Surg Pathol. 1998 Aug;22(8):934-44. doi: 10.1097/00000478-199808000-00003.
6
Percutaneous computed tomography-guided core needle biopsy can be used to histologically confirm the clinical features and long-term prognosis of pulmonary neuroendocrine neoplasms.经皮 CT 引导下的核心针活检可用于组织学证实肺神经内分泌肿瘤的临床特征和长期预后。
Jpn J Radiol. 2023 Dec;41(12):1414-1419. doi: 10.1007/s11604-023-01465-4. Epub 2023 Jul 3.
7
Analysis on the characteristics and prognosis of pulmonary neuroendocrine tumors.肺神经内分泌肿瘤的特征与预后分析
Asian Pac J Cancer Prev. 2014;15(5):2205-10. doi: 10.7314/apjcp.2014.15.5.2205.
8
Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung.肺切除神经内分泌肿瘤Ki-67增殖指数的自动化定量分析
Diagn Pathol. 2014 Oct 16;9:174. doi: 10.1186/s13000-014-0174-z.
9
Neuroendocrine tumors of the lung: A five-year retrospective experience of Egyptian NCI (2010-2014).肺神经内分泌肿瘤:埃及国家癌症研究所的五年回顾性经验(2010 - 2014年)
J Egypt Natl Canc Inst. 2018 Dec;30(4):151-158. doi: 10.1016/j.jnci.2018.10.005. Epub 2018 Nov 22.
10
Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors.PD-L1表达和CD8 + T细胞浸润在肺神经内分泌肿瘤中的预后意义
Diagn Pathol. 2018 May 22;13(1):30. doi: 10.1186/s13000-018-0712-1.

引用本文的文献

1
Exploring resistance to initial chemotherapy in small cell lung cancer: The role of bone metastasis and other clinicopathologic characteristics.探索小细胞肺癌对初始化疗的耐药性:骨转移及其他临床病理特征的作用
Medicine (Baltimore). 2025 Mar 21;104(12):e41953. doi: 10.1097/MD.0000000000041953.
2
Serum tumor markers: potential indicators for occult lymph node metastasis in clinical TNM small cell lung cancer patients.血清肿瘤标志物:临床 TNM 小细胞肺癌患者隐匿性淋巴结转移的潜在指标。
Respir Res. 2024 Sep 16;25(1):341. doi: 10.1186/s12931-024-02941-9.

本文引用的文献

1
Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.小细胞肺癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2021 Jul;32(7):839-853. doi: 10.1016/j.annonc.2021.03.207. Epub 2021 Apr 20.
2
Genomic Profiling and Clinicopathological Characteristics of Neuroendocrine Tumors of the Lung in East Asian Patients.东亚人群肺神经内分泌肿瘤的基因组分析及临床病理特征。
In Vivo. 2020 Nov-Dec;34(6):3375-3385. doi: 10.21873/invivo.12176.
3
Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric Cancer.
中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值以及中性粒细胞与淋巴细胞比值联合血小板与淋巴细胞比值在IV期晚期胃癌中的预后价值
Front Oncol. 2020 Jun 19;10:841. doi: 10.3389/fonc.2020.00841. eCollection 2020.
4
Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis.培美曲塞为基础的化疗在甲状腺转录因子 1(TTF-1)阴性、表皮生长因子受体/间变性淋巴瘤激酶(EGFR/ALK)阴性肺腺癌中劣于无培美曲塞方案:倾向评分匹配分析。
Clin Lung Cancer. 2020 Nov;21(6):e607-e621. doi: 10.1016/j.cllc.2020.05.014. Epub 2020 May 22.
5
Secretagogin, a marker for neuroendocrine cells, is more sensitive and specific in large cell neuroendocrine carcinoma compared with the markers CD56, CgA, Syn and Napsin A.分泌粒蛋白,一种神经内分泌细胞标志物,在大细胞神经内分泌癌中比标志物CD56、嗜铬粒蛋白A、突触素和Napsin A更敏感且更具特异性。
Oncol Lett. 2020 Mar;19(3):2223-2230. doi: 10.3892/ol.2020.11336. Epub 2020 Jan 23.
6
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression.不同癌胚抗原模式与肺癌进展的关系。
Sci Rep. 2020 Feb 7;10(1):2066. doi: 10.1038/s41598-020-59031-1.
7
Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers.胰岛素瘤相关蛋白 1(INSM1)在肺癌中的诊断价值及其与已建立的神经内分泌标志物的比较。
Arch Pathol Lab Med. 2020 Sep 1;144(9):1075-1085. doi: 10.5858/arpa.2019-0250-OA.
8
Comparative analysis of TTF-1 binding DNA regions in small-cell lung cancer and non-small-cell lung cancer.小细胞肺癌和非小细胞肺癌中 TTF-1 结合 DNA 区域的比较分析。
Mol Oncol. 2020 Feb;14(2):277-293. doi: 10.1002/1878-0261.12608. Epub 2019 Dec 15.
9
The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis.Ki-67作为肺神经内分泌肿瘤预后生物标志物的效用:系统评价和荟萃分析方案
BMJ Open. 2019 Aug 24;9(8):e031531. doi: 10.1136/bmjopen-2019-031531.
10
Inflammation and Cancer: Triggers, Mechanisms, and Consequences.炎症与癌症:触发因素、机制与后果。
Immunity. 2019 Jul 16;51(1):27-41. doi: 10.1016/j.immuni.2019.06.025.